Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular dystrophy(DMD)

 A young patient died due to cardiac arrest after receiving Pfizer's experimental gene therapy being tested in a mid-stage trial for a muscle-wasting disorder called Duchenne muscular dystrophy(DMD), the drugmaker told Reuters on Tuesday.

藥廠週二告訴路透社，一名年輕患者在接受輝瑞公司的實驗性基因療法後因心臟驟停而死亡，該療法正在一項名為杜氏肌肉營養不良症(DMD) 的肌肉萎縮性疾病的中期試驗中進行測試。